chrX-2938195-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4BP6_Very_StrongBS2
The NM_000047.3(ARSL):c.1189G>A(p.Gly397Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000404 in 1,210,715 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 168 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00046 ( 0 hom., 17 hem., cov: 24)
Exomes 𝑓: 0.00040 ( 0 hom. 151 hem. )
Consequence
ARSL
NM_000047.3 missense
NM_000047.3 missense
Scores
6
5
6
Clinical Significance
Conservation
PhyloP100: 6.54
Genes affected
ARSL (HGNC:719): (arylsulfatase L) Arylsulfatase E is a member of the sulfatase family. It is glycosylated postranslationally and localized to the golgi apparatus. Sulfatases are essential for the correct composition of bone and cartilage matrix. X-linked chondrodysplasia punctata, a disease characterized by abnormalities in cartilage and bone development, has been linked to mutations in this gene. Alternative splicing results in multiple transcript variants. A pseudogene related to this gene is located on the Y chromosome. [provided by RefSeq, Sep 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.4184788).
BP6
Variant X-2938195-C-T is Benign according to our data. Variant chrX-2938195-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 522724.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 17 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARSL | NM_000047.3 | c.1189G>A | p.Gly397Arg | missense_variant | 9/11 | ENST00000381134.9 | NP_000038.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARSL | ENST00000381134.9 | c.1189G>A | p.Gly397Arg | missense_variant | 9/11 | 1 | NM_000047.3 | ENSP00000370526.3 |
Frequencies
GnomAD3 genomes AF: 0.000462 AC: 52AN: 112675Hom.: 0 Cov.: 24 AF XY: 0.000488 AC XY: 17AN XY: 34815
GnomAD3 genomes
AF:
AC:
52
AN:
112675
Hom.:
Cov.:
24
AF XY:
AC XY:
17
AN XY:
34815
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000538 AC: 98AN: 182070Hom.: 0 AF XY: 0.000491 AC XY: 33AN XY: 67168
GnomAD3 exomes
AF:
AC:
98
AN:
182070
Hom.:
AF XY:
AC XY:
33
AN XY:
67168
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000398 AC: 437AN: 1098040Hom.: 0 Cov.: 34 AF XY: 0.000415 AC XY: 151AN XY: 363472
GnomAD4 exome
AF:
AC:
437
AN:
1098040
Hom.:
Cov.:
34
AF XY:
AC XY:
151
AN XY:
363472
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000462 AC: 52AN: 112675Hom.: 0 Cov.: 24 AF XY: 0.000488 AC XY: 17AN XY: 34815
GnomAD4 genome
AF:
AC:
52
AN:
112675
Hom.:
Cov.:
24
AF XY:
AC XY:
17
AN XY:
34815
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
71
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
X-linked chondrodysplasia punctata 1 Pathogenic:1
Likely pathogenic, flagged submission | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Dec 03, 2017 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 19, 2024 | Variant summary: ARSL c.1189G>A (p.Gly397Arg) results in a non-conservative amino acid change located in the N-terminal domain (IPR000917) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0006 in 203935 control chromosomes, including 42 hemizygotes. The occurrence in several hemizygotes suggests that this variant is likely not associated with a high penetrance, severe, early onset disease phenotype in hemizygous state. To our knowledge, no occurrence of c.1189G>A in individuals affected with Chondrodysplasia Punctata 1, X-Linked Recessive and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 522724). Based on the evidence outlined above, the variant was classified as likely benign. - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 08, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Chondrodysplasia punctata, brachytelephalangic, autosomal Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Connective tissue disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | May 18, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Pathogenic
D;.;D
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Pathogenic
D
MutationAssessor
Benign
.;.;L
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D
REVEL
Pathogenic
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
D;D;D
Vest4
MutPred
Gain of MoRF binding (P = 0.0111);.;.;
MVP
MPC
1.4
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at